D-0496-2026 Class II Ongoing
FDA drug recall D-0496-2026 was initiated by B BRAUN MEDICAL INC on Apr 2, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. The recall status is ongoing. Affected quantity: 17,124 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 29, 2026
- Initiation Date
- Apr 2, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,124 bags
Product description
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
Reason for recall
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Distribution pattern
US Nationwide.
Code information
Lot # J5H166, J5H167, Exp Date: 30NOV2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0496-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026